J&J Vaccine Receives Additional Warning About Bleeding Side Effect
U.S. regulators have revised the COVID-19 vaccine fact sheet from Johnson & Johnson to warn of the risk of a rare bleeding disorder. The Food and Drug Administration said in a letter to the company on Tuesday that adverse event reports suggested an increased risk of immune thrombocytopenia, or ITP, during the 42 days after … Read more